Articles
Volume 7 (2009) - December 2009
|
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis Feng Xie, Gord Blackhouse, Nazila Assasi, Kathryn Gaebel, Diana Robertson, Ron Goeree Cost Effectiveness and Resource Allocation 2009, 7:20 (11 December 2009) |

